380 related articles for article (PubMed ID: 25455733)
1. Old drug, new trick: repurposing metformin for gynecologic cancers?
Febbraro T; Lengyel E; Romero IL
Gynecol Oncol; 2014 Dec; 135(3):614-21. PubMed ID: 25455733
[TBL] [Abstract][Full Text] [Related]
2. Metformin and gynecologic cancers.
Stine JE; Bae-Jump V
Obstet Gynecol Surv; 2014 Aug; 69(8):477-89. PubMed ID: 25144611
[TBL] [Abstract][Full Text] [Related]
3. The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses.
Wen Q; Zhao Z; Wen J; Zhou J; Wu J; Lei S; Miao Y
Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():33-41. PubMed ID: 31009857
[TBL] [Abstract][Full Text] [Related]
4. [Metformin--new treatment strategies for gynecologic neoplasms].
Milewicz T; Kiałka M; Mrozińska S; Ociepka A; Krzysiek J
Przegl Lek; 2013; 70(2):81-4. PubMed ID: 23879009
[TBL] [Abstract][Full Text] [Related]
5. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
Husseinzadeh N; Husseinzadeh HD
Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
[TBL] [Abstract][Full Text] [Related]
6. Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.
Gadducci A; Biglia N; Tana R; Cosio S; Gallo M
Crit Rev Oncol Hematol; 2016 Sep; 105():73-83. PubMed ID: 27378194
[TBL] [Abstract][Full Text] [Related]
7. Physical activity and gynecologic cancer prevention.
Cust AE
Recent Results Cancer Res; 2011; 186():159-85. PubMed ID: 21113764
[TBL] [Abstract][Full Text] [Related]
8. Primary prevention of gynecologic cancers.
Grimes DA; Economy KE
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):227-35. PubMed ID: 7847546
[TBL] [Abstract][Full Text] [Related]
9. Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review.
Ahmed ZSO; Golovoy M; Abdullah Y; Ahmed RSI; Dou QP
Recent Pat Anticancer Drug Discov; 2021; 16(2):161-186. PubMed ID: 34132186
[TBL] [Abstract][Full Text] [Related]
10. Perspectives of metformin use in endometrial cancer and other gynaecological malignancies.
Barczyński B; Frąszczak K; Kotarski J
J Drug Target; 2022 Apr; 30(4):359-367. PubMed ID: 34753372
[TBL] [Abstract][Full Text] [Related]
11. Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena.
Martin-Castillo B; Vazquez-Martin A; Oliveras-Ferraros C; Menendez JA
Cell Cycle; 2010 Mar; 9(6):1057-64. PubMed ID: 20305377
[TBL] [Abstract][Full Text] [Related]
12. The impact of obesity on the incidence and treatment of gynecologic cancers: a review.
Modesitt SC; van Nagell JR
Obstet Gynecol Surv; 2005 Oct; 60(10):683-92. PubMed ID: 16186785
[TBL] [Abstract][Full Text] [Related]
13. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling.
Ruiz-Mitjana A; Vidal-Sabanés M; Navaridas R; Perramon-Güell A; Yeramian A; Nicholson-Sabaté N; Egea J; Encinas M; Matias-Guiu X; Dolcet X
Biomed Pharmacother; 2023 Dec; 168():115817. PubMed ID: 37925934
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA and gynecologic cancers.
Kanekura K; Nishi H; Isaka K; Kuroda M
J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
[TBL] [Abstract][Full Text] [Related]
15. DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells.
Obara A; Fujita Y; Abudukadier A; Fukushima T; Oguri Y; Ogura M; Harashima S; Hosokawa M; Inagaki N
Biochem Biophys Res Commun; 2015 May; 460(4):1047-52. PubMed ID: 25843797
[TBL] [Abstract][Full Text] [Related]
16. Metformin: taking away the candy for cancer?
Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
18. Multidimensional mechanisms of metformin in cancer treatment.
Singh-Makkar S; Pandav K; Hathaway D; Paul T; Youssef P
Tumori; 2022 Apr; 108(2):111-118. PubMed ID: 34139918
[TBL] [Abstract][Full Text] [Related]
19. Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.
Liu Y; Qin A; Li T; Qin X; Li S
Gynecol Oncol; 2014 Jun; 133(3):647-55. PubMed ID: 24736024
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopy in gynecologic malignancies.
Chi DS
Oncology (Williston Park); 1999 Jun; 13(6):773-82; discussion 782-5 passim. PubMed ID: 10378217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
